Breaking down CMND’s current quarter earnings estimates

In the current trading session, Clearmind Medicine Inc’s (CMND) stock is trading at the price of $1.01, a gain of 11.85% over last night’s close. So, the stock is trading at a price that is -56.09% less than its 52-week high of $2.30 and 26.25% better than its 52-week low of $0.80. Based on the past 30-day period, the stock price is -20.34% below the high and +30.45% above the low.

The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, CMND’s SMA-200 is $1.2158.

CMND’s price to book ratio for the most recent quarter was 2.25, resulting in an 1.17 price to cash per share for the period.

How does Clearmind Medicine Inc (CMND) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.

Clearmind Medicine Inc (CMND): Earnings History

If we examine Clearmind Medicine Inc’s recent earnings history, in the last quarter ended on Next Year (1970), it posted adjusted earnings per share of $0, slashing the consensus of $0. In other words, it topped the consensus by $0, resulting in a 0 surprise. In the 3 months period before the previous quarter which was closed on Next Year (1970), the stock recorded adjusted earnings per share of $0 in contrast with the Outlook of $0. That was a difference of $0 and a surprise of 0.

Clearmind Medicine Inc (NASDAQ: CMND) Ownership Details

I will give a breakdown of the key shareholders in Clearmind Medicine Inc (CMND). Recent figures show that the company’s insiders hold 2.80% of shares. A total of 7 institutional investors hold shares in the company, making 11.19% of its stock and 11.51% of its float.

Mar 31, 2025 , it was reported that the Company’s largest institutional holder is Gotham Asset Management, LP holding total of 343.43 shares that make 8.05% of the company’s total number of shares and are currently priced at 0.35 million.

The securities firm AdvisorShares Investments, LLC holds 220.93 shares of CMND, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 5.18% , and the holding percentage of shares is valued at 0.23 million.

An overview of Clearmind Medicine Inc’s technicals

In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Clearmind Medicine Inc (CMND) traded 2,042,539 shares per day, with a moving average of $0.8987 and price change of +0.1395. With the moving average of $0.9503 and a price change of +0.0436, about 857,466 shares changed hands on average over the past 50 days. Finally, CMND’s 100-day average volume is 560,021 shares, alongside a moving average of $1.0431 and a price change of -0.3164.

Hot this week

Amneal Pharmaceuticals Inc (AMRX) stock analysis: A simple moving average approach

While Amneal Pharmaceuticals Inc has overperformed by 2.03%, investors...

Xeris Biopharma Holdings Inc (XERS)’s highs and lows: A closer look at its stock price fluctuations

While Xeris Biopharma Holdings Inc has underperformed by -1.13%,...

A year in review: Cenovus Energy Inc (CVE)’s performance in the last year

While Cenovus Energy Inc has overperformed by 0.12%, investors...

SPRY underperforms with a -4.32 decrease in share price

While ARS Pharmaceuticals Inc has underperformed by -4.32%, investors...

Technical analysis of NXP Semiconductors NV (NXPI) stock chart patterns

While NXP Semiconductors NV has overperformed by 0.59%, investors...

Topics

Amneal Pharmaceuticals Inc (AMRX) stock analysis: A simple moving average approach

While Amneal Pharmaceuticals Inc has overperformed by 2.03%, investors...

A year in review: Cenovus Energy Inc (CVE)’s performance in the last year

While Cenovus Energy Inc has overperformed by 0.12%, investors...

SPRY underperforms with a -4.32 decrease in share price

While ARS Pharmaceuticals Inc has underperformed by -4.32%, investors...

Technical analysis of NXP Semiconductors NV (NXPI) stock chart patterns

While NXP Semiconductors NV has overperformed by 0.59%, investors...

Eastman Kodak Co (KODK) stock shows negative growth on Thursday

While Eastman Kodak Co has underperformed by -1.19%, investors...

Werner Enterprises, Inc (WERN) deserves deeper analysis

While Werner Enterprises, Inc has underperformed by -0.35%, investors...

Was OppFi Inc (OPFI)’s session last reading good?

While OppFi Inc has overperformed by 0.10%, investors are...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.